Author

C. K. A. Neumann

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Research Focus:cancer & tumor microenvironment· 3 Approach:experimental assay· 3 Assay:proteomics· 3 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

J. M. Brown· 4 shared D. J. Silver· 3 shared J. D. Lathia· 3 shared K. M. Troike· 2 shared R. Zhang· 2 shared A. Lauko· 1 shared A. Rabljenovic· 1 shared A. Steffens· 1 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

J. M. Brown

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

The MIF SNP rs755622 is a germline determinant of tumor immune activation in Glioblastoma

T. Alban, M. M. Grabowski, B. Otvos, D. B. Watson, A. Zalavadia, V. Makarav, K. M. Troike, M. McGraw, A. Rabljenovic, A. Lauko, C. K. A. Neumann, G. Roversi, K. Waite, G. Cioffi, N. Patil, , J. Lathia

The paper identifies a germline SNP, rs755622, associated with increased leukocyte infiltration in glioblastoma and links it to lactotransferrin expression as a potential biomarker for immune activation.

bioRxiv · Mar 7, 2022 · PreprintCancer Biology

Cancer Stem Cell Enrichment and Metabolic Substrate Adaptability are Driven by Hydrogen Sulfide Suppression in Glioblastoma

D. J. Silver, G. A. Roversi, N. Bithi, C. K. A. Neumann, K. M. Troike, G. K. Ahuja, O. Reizes, J. M. Brown, C. Hine, J. D. Lathia

A high-fat diet accelerates glioblastoma by inhibiting hydrogen sulfide production, leading to cancer stem cell enrichment and reduced treatment response.

bioRxiv · Mar 8, 2020 · PreprintCancer Biology

Membrane-Bound O-Acyltransferase 7 (MBOAT7) is a Key Regulator of Glycolysis in Clear Cell Renal Carcinoma.

C. K. A. Neumann, W. Massey, D. Orabi, R. Zhang, D. J. Silver, J. D. Lathia, J. M. Brown

This study shows MBOAT7 regulates glycolysis in ccRCC by reducing glycolytic gene expression, intermediates, and respiration, and improving survival in xenograft models.

bioRxiv · Feb 10, 2020 · PreprintCancer Biology

MBOAT7-Driven Phosphatidylinositol Remodeling Promotes the Progression of Clear Cell Renal Cell Carcinoma.

C. K. A. Neumann, R. Zhang, D. J. Silver, V. Venkaleshwari, C. A. Traughber, C. Przybycin, D. Bayik, J. D. Smith, J. D. Lathia, B. I. Rini, J. M. Brown

This study identifies MBOAT7-driven phosphatidylinositol remodeling as a driver of clear cell renal cell carcinoma progression and highlights MBOAT7 as a potential therapeutic target.

bioRxiv · May 23, 2019Cancer Biology